CAPITOL HILL CONSULTING GROUP

Lobbying for HUMACYTE · Biotechnology platform for vascular diseases.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $50,000.00 income · posted Oct 21, 2025

Lobbying activity 3

Medicare/Medicaid

Payment for approved medical devices.

Health Issues

Payment for approved medical devices.

Defense

Payment for approved medical devices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.